Shi Yao Holding Group Co., Ltd. is a national innovative enterprise integrating R&D, innovative drug production and sales. The total assets of the whole group are 4 1 100 million yuan, and the market value of listed companies in Hong Kong exceeds100 billion Hong Kong dollars. It is an integral part of the Hang Seng Index and the first pharmaceutical stock in the 50 years since the index was compiled.
2065438+On March 22nd, 2009, its subsidiary, Sanofi, was successfully listed on the Growth Enterprise Market, and Younuokang realized a new era of red chip +A+ New Third Board financing pattern.
Unacon has achieved sustained, healthy and rapid development with the strong support from all walks of life since its establishment.
At present, there are 1 1 pharmaceutical production bases in Hebei, Shanxi, Shandong, Jiangsu, Jiangxi, Tianjin and other provinces and cities. The products are sold to more than 0/00 countries and regions around the world, and the sales of 33 varieties exceed 100 million yuan. In 20 18, the whole group achieved sales revenue of 30.068 billion yuan and paid various taxes of 2.76 billion yuan.
Driven by scientific and technological innovation, we take the lead in realizing the continuous iteration of technology and products through thinking innovation, management innovation, market innovation, R&D innovation, product innovation, talent innovation, multi-round drive and multi-point efforts.
Constantly create new standards for industry segmentation, and then promote the progress of the whole industry.
Innovation is endurance, strength, doing what others can't do, and innovation is always full of vitality and vitality.
Always keep curiosity and exploration of new things, keep a global vision, uphold diversified thinking, embrace change, keep pace with the times, break all inherent concepts, persist in criticism and self-criticism, establish a scientific and inclusive innovation mechanism, and be tolerant, cooperative and complementary with a broad mind to create great achievements.